Itraconazole (130 mg) & CONARIS SB 130 :Affordable Sterispharma Pharmaceuticals: Shop Online

CONARIS SB 130

Itraconazole (130 mg)

CONARIS SB 130 encapsulates the therapeutic prowess of Itraconazole 130mg. This article elucidates its diverse applications, recommended dosage, potential side effects, pricing insights, and a comprehensive conclusion on its efficacy.

Understanding the Uses of CONARIS SB 130

1. Fungal Infections: CONARIS SB 130 is primarily prescribed for the treatment of various fungal infections, including but not limited to:
   • Dermatophytosis (such as ringworm infections)
   • Candidiasis (yeast infections)
   • Aspergillosis
   • Histoplasmosis
2. Systemic Mycoses: It is also effective against systemic fungal infections affecting organs like the lungs, liver, and kidneys.

Dosage Guidelines for CONARIS SB 130

1. Initial Treatment: The typical starting dose for CONARIS SB 130 is 130mg once daily.
2. Duration of Therapy: The duration of treatment varies based on the type and severity of the fungal infection, ranging from weeks to several months.
3. Medical Supervision: Always follow your healthcare provider's instructions regarding dosage adjustments and duration of therapy.

Potential Side Effects of CONARIS SB 130

1. Liver Function: Monitor liver function tests during prolonged use, as Itraconazole can affect liver enzymes.
2. Drug Interactions: Exercise caution when using CONARIS SB 130 with other medications, as interactions may occur. 

Pricing and Affordability of CONARIS SB 130

1. Cost Considerations: CONARIS SB 130 is available at varying price points, depending on the brand, dosage, and pharmacy.
2. Insurance Coverage: Check with your insurance provider for coverage options that may reduce out-of-pocket expenses.
3. Generic Alternatives: Generic versions of Itraconazole may offer a more cost-effective option without compromising efficacy.

Conclusion: CONARIS SB 130 - A Potent Antifungal Solution

In conclusion, CONARIS SB 130 represents a reliable choice in combating fungal infections with the potency of Itraconazole. Its versatile applications, coupled with appropriate dosage management and vigilance for potential side effects, make it a valuable asset in clinical practice for patients requiring antifungal therapy. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW